Sheikh Khalifa Medical City

Abu Dhabi’s Sheikh Khalifa Medical City leads the region for cardiac services

Cardiovascular disease is the world’s leading cause of death, claiming about 17.3 million lives a year, according to World Health Organisation data. It accounts for one in four deaths in the UAE, according to the Abu Dhabi Health Authority.

The Institute of Cardiac Sciences at Sheikh Khalifa Medical City (SKMC) is one of the leading programs in the Gulf region with state-of-the-art technology to prevent and treat cardiovascular disease in all age groups.

SKMC achieved Cycle 4 Chest Pain Center Accreditation in 2012 – among only a handful worldwide and the only such institute outside of the US – and maintains an affiliation with the American College of Cardiology.

At the national level, SKMC offers the most comprehensive adult arrhythmia and electrophysiology (EP) service, the first echocardiography service to be accredited by the European Association of Cardiovascular Imaging, the longest running 24/7 Primary PCI program, a unique smoking cessation program, the largest adult cardiac surgery program, the only advanced paediatric interventional cardiology program, the largest paediatric cardiac surgery program, and the most productive collaborative cardiovascular outcomes research portfolio.

The SEHA heart rhythm team at SKMC recently added a unique technology known as cryoablation to its EP service. Recently, the SEHA EP team at SKMC used cryoablation to cure a young Emirati patient from an arrhythmia that has caused his heart to weaken. The young patient had an arrhythmia originating from an area very close to his main heart conduction system, and radiofrequency was too dangerous to use. The availability of cryoablation technology at SKMC offered him an opportunity for cure.

SKMC also has the only dedicated paediatric cardiac surgical program in the country, serving an estimated newborn population of over 80,000. More than 500 newborns per year are born with congenital heart disease (CHD) with nearly 70% requiring surgical intervention, and almost all within the first year of life.

In 2013, SKMC’s cardiac surgery program reached over 1800 surgeries conducted since its inception, and currently performs over 400 heart operations per year, offering hope the chance of a happy and fulfilling life for children with congenital heart disorders who would otherwise have faced ill-health or death.

In addition to operating on children with congenital heart disorders, the paediatric cardiac surgery team treat adolescents and adults that were born with cardiac defects and who weren’t able to have their problems resolved in their youth. SKMC’s Grown Up Congenital Heart or ‘GUCH’ program is another initiative that is the only one of its kind in the country. The GUCH program treats patients who often fall into a ‘grey area’, between children and adults, so a multidisciplinary input is required involving both the hospital’s adult and paediatric services.

The paediatric cardiac surgery division has the country’s only Extracorporeal Membrane Oxygenation (ECMO) program for paediatric patients, which is an advanced form of life support used to treat infants and children in cardiac and/ or respiratory failure. It works as a modified form of heart and lung bypass on a temporary basis, and is an alternative to conventional methods of life support.

Recent awards include the Silver Recognition Award by the American Heart Association for its International Training Centre and induction into the American College of Cardiology’s International Centres of Excellence Program.
 


Eucarbon



Eucarbon – the essence of bowel history

       

2500 years of experience dedicated to your bowel health

By Dr Johannes Gottfried Mayer

Whenever the topic “Traditional Medicine” comes up, it makes people think of the traditional Chinese medicine. Yet, people tend to forget, that also the European medicine is steeped in tradition. For hundreds and thousands of years, it has been strongly influenced by various healing arts, which are primarily based in Asia Minor and the Arab regions. Groundbreaking findings in research and science are the reason that European-based traditional medical methods fell into oblivion. Lately, it is, amongst other things, the findings gathered from the herbalism in the medieval cloister gardens, which is putting the topic back into focus.

Eucarbon is a preparation made up of four agents, which are used in the traditional European art of healing. It was developed by the pharmacists F. Trenk and Prof. Wolfgang Pauli in 1909. It is applied as mild bowel regulator, helps to relieve constipation, slight diarrhea, and flatulence – and binds toxic metabolic products. One tablet contains:

l Senna leaves (Folium Sennae) 105 mg l Rhubarb extract (Extractum Rhei) 25 mg l Natural coal (Carbo ligni) 180 mg l Purified sulfur (Sulfur depuratum) 50 mg

Rhubarb from the land of the Barbarians

Rhubarb has its name from the river Wolga, which the Greeks used to call Rha. Hence, from the Greeks’ point of view, it originated beyond the Black Sea – the home of the Barbarians; that’s how the plant Rhubarb got its name. Its healing effects were discovered by Greek physicians back in ancient times (≈ 2000 BC – 500 AD). It turned out that the spectrum of its healing effects was very wide. We’d like to focus on those related to the stomach and bowel. The Greek physician Dioskurides was convinced of the relieving effect of rhubarb when applied against eructation, flatulence, digestive problems, and colics. The Roman civil servant Pliny the Elder held the same view. It was in the 9th century AD, when the medicinal rhubarb contained in Eucarbon was discovered by the Arabs in the course of their journeys to China. They brought their knowledge about the plant and its increased effects to Europe. Besides, its significance is higher than assumed.

“If there is anything that can contribute to avoiding death, it is Senna”

Prophet Mohammed, 1. Hadith, based on the book “Sunanihi” written by Tarmidi and Ibn Maja.

The name Senna or Cassia derives from the Arab term “sanâ” or “sannâ”. The physicians of the ancient Europe didn’t know anything about this medicinal plant until the famous healers of Arab’s cultural spheres conveyed their knowledge to them in the 9th and 10th century. The plant conquered the field of European medicine thanks to the findings of the Arabs, and was firstly applied in Italy. Back in the 16th century, the city physician Adam Lonitzer from Frankfurt (Germany) described the correlation of rhubarb and senna; according to him, the formula can be used to get rid of undesired “liquids” as it was referred to by people, then – and purify the blood. The combination rhubarb and senna was also mentioned by other researchers and authors of works on that topic, which were published later on.

Sulfur – The yellow healing powder

The use of sulfur in the art of healing goes back to early times, too. Sulfur was considered to be a remedy by both the Egyptians and the Greeks. The Arab physician Ibn Sina (Avicenna, 980-1037) describes the use of sulfur as a remedy against skin diseases, ulcers, respiratory infections, liver and spleen diseases, painful womb conditions, and temperature. Also the renowned physician Paracelsus (about 1493-1541) recognized the astonishing effects of sulfur and regarded it as one of the most important active pharmaceutical ingredients. In the late 19th century, the oral application of sulfur added to combined preparations, which also supported the bowel movements owing to its mild laxative effect, found its way into the European Pharmacopoeia and was used with different names (e.g. Pulvis Liquiritae Compositum Laxatives, Kurella´s powder…)

Charcoal - Carbo ligni

Other than the medicinal plants known to exist since ancient times, evidences for the use of charcoal for medical purposes showed up quite late. The German alternative physician Johann Rudolf Osiander (1717-1801) used charcoal as a treatment against “acid regurgitation, gastric acid, foul-smelling wind… The same means can be applied to get rid of bad breath and stimulates the bowel movement.” The use of charcoal has been constantly increasing; apart from that, it is known and appreciated to bind toxic agents.

Eucarbon – the best preparation for an ideal bowel movement based on 2000 years of medical experience

The four most important ingredients of Eucarbon are known to be significant means of traditional medicine in Europe and the Middle East. In 1909, they were combined for the very first time in Eucarbon. Since then, Eucarbon, which is produced in Austria, is regarded as an indispensable preparation to treat bowel irritation in a smooth way. www.eucarbon.com

The author
Dr Johannes Gottfried Mayer Forschergruppe Klostermedizin GmbH Mozartstraße 1, D-97074 Würzburg www.klostermedizin.de
 

Al Kifah

Breaking the chain of cross infection with the first Medical Pulp Disposables manufactured in Saudi Arabia

Al Kifah is a large, privately owned group headquartered in Saudi Arabia that currently employs more than 8,000 people.

The Paper Products Division has been a market leader, supplying the region’s leading dairy, medical and food companies for almost 30 years. The Division is accredited with ISO 9001, ISO 22000 and was the first non-food producing company to achieve BRC certification in the Kingdom.

In 2014, Al Kifah assembled a team with close to 30 years’ experience in pulp moulding technology and completed the commissioning of a new multi-million dollar, advanced paper pulp moulding facility. This investment was made to address a growing demand in the region for locally manufactured products to minimize the increasing problem of supply chain interruptions.

The company’s discussions with hospitals throughout the region identified a growing demand for disposable medical products to help combat the risk of cross infection. During the discussions it became clear, that Hospitals wanted a local manufacturer as a result of the issues normally associated with imported products.

A full range of Medical Pulp Disposables

Al Kifah recognized the need to supply a complete medical disposables system to the hospitals, developing a full range of medical pulp disposables that includes, Bed Pans, Urinal Bottles and Kidney Trays, etc… In addition, after completing an analysis of the leading macerator suppliers, Al Kifah identified DDC Dolphin Limited as the market leading manufacturer, based upon their ongoing investment in R&D and their commitment to innovation. DDC was the first company to introduce a completely “Hands Free” Macerator solution.

Last year, Al Kifah partnered with DDC Dolphin Limited to become the exclusive distributor in the Saudi Arabian market for the complete range of DDC products which include, Pulp Macerators, Incontinence Macerators and Washer Disinfectors.

Al Kifah maintains an inventory of DDC Macerators at their facility in Al Ahsa in the Eastern Region of Saudi Arabia. They have also assembled a team of factory trained technicians, who are able to maintain and service all DDC manufactured equipment, ensuring that hospitals receive a fast and efficient service. The technicians provide ongoing training to nursing staff and guarantee the long and productive life of the DDC machines.

Al Kifah will be supplying their Disposable Medical Pulp Products throughout Saudi Arabia and the GCC, to support the growing medical sector. Successful trials of Al Kifah’s new medical disposables system have already taken place at a number of locations in Saudi Arabia and the company is expecting several large Hospital Group installations during the First Quarter of 2015.

Please visit the DDC Dolphin Stand at Arab Health 2015. Stand Number Z1B50 in the UK Pavilion, where Al Kifah representatives will be pleased to discuss your specific needs.
- For additional information regarding Al Kifah’s Paper Products Division, please visit www.kifahpaper.com
- For additional information regarding DDC Dolphin Limited, please visit www.ddcdolphin.co.uk


Advantech Digital Healthcare


The Paradigm Shift in Healthcare Information Technology is Accelerating the Realization of Smart Hospitals



Hospitals today are being transformed into sophisticated medical facilities with computer- based medical equipment and intelligent, connected medical devices. According to a 2014 Statista report, the value of the mobile healthcare industry is expected to quadruple over the next 6 years. The increasing deployment of technology in hospitals, enables healthcare providers to optimize not only staff workflows, but also the services provided to patients. Thus, trusted and experienced hospital information technology (IT) solution providers are crucial to the delivery of effective, safe, and quality healthcare. Advantech is committed to assisting hospitals with implementing technical solutions that improve outpatient services, nursing care, and critical care.

Hospitals of the future

An illustration of a smart hospital is provided on page 19 of this month’s issue. Imagine walking into a hospital and not experiencing long queues because of the self-check in system installed at the service desk and connected to the Hospital Information System (HIS). Next, you are not only guided to the appropriate department, but the doctor already knows the reason for your visit. As you pass by the nursing station, you observe nurses and other healthcare staff using either mobile clinical pads or medication carts with vital sign measurements for updating patient records while on the move. Clinical mobility solutions prevent interruptions to internal hospital workflows. Furthermore, with the use of medical-grade IPcertified, fanless POC-W series equipment in operating rooms and intensive care units, doctors and nurses no longer have to worry about bacterial control. What about the patients residing in hospital wards? In smart hospitals, patients feel less isolated with the implementation of patient infotainment systems. These systems enable patients to easily access their medical records, watch television, order food, and even communicate with their family and friends over the Internet, without using their personal devices. Regarding emergency admission registration from ambulances, by synchronizing patient data and conducting initial diagnostics prior to hospital arrival, precious treatment time and patient lives can be saved. Additional time can be saved by using Advantech’s TREK fleet management series to guide ambulance drivers and provide them with real-time route information. Every one of Advantech’s high-tech solutions contributes to digitalization and the realization of smart hospitals. At Advantech, we believe that saving time equate to saving lives.

Worldwide applications

Advantech has successfully delivered smart hospital IT solutions to many world-renowned hospitals and organizations such as Hamad Medical Corporation (Qatar), TATA Hospital (India), Han Yang University Hospital (Korea, Richard Wolf GmbH (Germany), Netherland Cancer Institute (Netherland), King Khalid University Hospital (Saudi), and Cleveland Clinic (UAE). For a complete list of installations worldwide, please visit our website or contact our local specialists for more information.

About Advantech

Digital Healthcare Founded in 1983, Advantech is a leading provider of information technology solutions for the digital healthcare market. Our years of trusted experience combined with comprehensive medical, ISO, and IP certifications attest to the quality of our uniquely designed products. Advantech has a full range of medical products for satisfying all demands, medical technology and implementation research and development teams, extensive customization capabilities, as well as global sales and service teams that guarantee a rapid time-to-market and local support. The future hospital applications and innovations made possible by using Advantech products are unlimited. For more information, please visit www.advantech.com/digital-healthcare


 
Date of upload: 10th Jan 2015

 

                                  
                                               Copyright © 2014 MiddleEastHealthMag.com. All Rights Reserved.